vs
Side-by-side financial comparison of CS Disco, Inc. (LAW) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
CS Disco, Inc. is the larger business by last-quarter revenue ($41.2M vs $39.6M, roughly 1.0× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -20.7%, a 56.5% gap on every dollar of revenue. On growth, CS Disco, Inc. posted the faster year-over-year revenue change (11.3% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $255.0K). Over the past eight quarters, CS Disco, Inc.'s revenue compounded faster (7.6% CAGR vs -15.0%).
CS Disco, Inc. is a leading legal technology provider that develops cloud-based software solutions for legal practitioners. Its core offerings include e-discovery, document review, case management, and legal workflow automation tools, serving law firms, corporate legal teams, and government legal departments primarily in North America.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
LAW vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.2M | $39.6M |
| Net Profit | $-8.5M | $14.2M |
| Gross Margin | 75.1% | 73.1% |
| Operating Margin | -22.4% | 32.5% |
| Net Margin | -20.7% | 35.9% |
| Revenue YoY | 11.3% | -10.9% |
| Net Profit YoY | 66.3% | 117.2% |
| EPS (diluted) | $-0.13 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.2M | $39.6M | ||
| Q3 25 | $40.9M | $43.4M | ||
| Q2 25 | $38.1M | $43.4M | ||
| Q1 25 | $36.7M | $47.3M | ||
| Q4 24 | $37.0M | $44.4M | ||
| Q3 24 | $36.3M | $53.1M | ||
| Q2 24 | $36.0M | $53.1M | ||
| Q1 24 | $35.6M | $54.8M |
| Q4 25 | $-8.5M | $14.2M | ||
| Q3 25 | $-13.7M | $12.8M | ||
| Q2 25 | $-10.8M | $2.5M | ||
| Q1 25 | $-11.4M | $21.5M | ||
| Q4 24 | $-25.2M | $6.5M | ||
| Q3 24 | $-9.2M | $2.8M | ||
| Q2 24 | $-10.8M | $18.5M | ||
| Q1 24 | $-10.6M | $18.8M |
| Q4 25 | 75.1% | 73.1% | ||
| Q3 25 | 75.5% | 70.6% | ||
| Q2 25 | 74.6% | 69.2% | ||
| Q1 25 | 74.1% | 79.7% | ||
| Q4 24 | 74.2% | 76.3% | ||
| Q3 24 | 73.1% | 81.5% | ||
| Q2 24 | 74.2% | 74.2% | ||
| Q1 24 | 75.1% | 72.1% |
| Q4 25 | -22.4% | 32.5% | ||
| Q3 25 | -35.3% | 36.6% | ||
| Q2 25 | -31.0% | 33.6% | ||
| Q1 25 | -34.4% | 51.1% | ||
| Q4 24 | -70.6% | 10.6% | ||
| Q3 24 | -30.0% | 26.1% | ||
| Q2 24 | -34.4% | 51.4% | ||
| Q1 24 | -34.7% | 44.6% |
| Q4 25 | -20.7% | 35.9% | ||
| Q3 25 | -33.4% | 29.6% | ||
| Q2 25 | -28.4% | 5.7% | ||
| Q1 25 | -31.1% | 45.4% | ||
| Q4 24 | -68.1% | 14.7% | ||
| Q3 24 | -25.3% | 5.3% | ||
| Q2 24 | -30.1% | 34.8% | ||
| Q1 24 | -29.7% | 34.2% |
| Q4 25 | $-0.13 | $0.15 | ||
| Q3 25 | $-0.22 | $0.12 | ||
| Q2 25 | $-0.18 | $0.02 | ||
| Q1 25 | $-0.19 | $0.21 | ||
| Q4 24 | $-0.43 | $0.05 | ||
| Q3 24 | $-0.15 | $0.03 | ||
| Q2 24 | $-0.18 | $0.20 | ||
| Q1 24 | $-0.17 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.6M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $128.1M | $248.3M |
| Total Assets | $173.6M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.6M | $164.1M | ||
| Q3 25 | $113.5M | $127.4M | ||
| Q2 25 | $114.5M | $152.7M | ||
| Q1 25 | $118.8M | $132.1M | ||
| Q4 24 | $129.1M | $125.0M | ||
| Q3 24 | $126.8M | $137.4M | ||
| Q2 24 | $130.0M | — | ||
| Q1 24 | $148.7M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $128.1M | $248.3M | ||
| Q3 25 | $130.6M | $248.0M | ||
| Q2 25 | $137.9M | $244.6M | ||
| Q1 25 | $142.2M | $226.4M | ||
| Q4 24 | $147.5M | $195.1M | ||
| Q3 24 | $167.3M | $205.0M | ||
| Q2 24 | $170.9M | $8.8M | ||
| Q1 24 | $193.2M | $9.0M |
| Q4 25 | $173.6M | $380.4M | ||
| Q3 25 | $174.8M | $321.4M | ||
| Q2 25 | $164.9M | $315.3M | ||
| Q1 25 | $168.0M | $284.6M | ||
| Q4 24 | $180.3M | $266.1M | ||
| Q3 24 | $194.4M | $296.5M | ||
| Q2 24 | $198.0M | $19.5M | ||
| Q1 24 | $217.3M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $762.0K | $52.0M |
| Free Cash FlowOCF − Capex | $255.0K | $51.2M |
| FCF MarginFCF / Revenue | 0.6% | 129.3% |
| Capex IntensityCapex / Revenue | 1.2% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-18.0M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $762.0K | $52.0M | ||
| Q3 25 | $-979.0K | $-20.9M | ||
| Q2 25 | $-4.2M | $-8.3M | ||
| Q1 25 | $-10.5M | $1.9M | ||
| Q4 24 | $2.1M | $-7.3M | ||
| Q3 24 | $-2.9M | $5.0M | ||
| Q2 24 | $-650.0K | $19.2M | ||
| Q1 24 | $-7.3M | $3.7M |
| Q4 25 | $255.0K | $51.2M | ||
| Q3 25 | $-2.0M | $-20.9M | ||
| Q2 25 | $-5.2M | $-8.6M | ||
| Q1 25 | $-11.0M | $1.7M | ||
| Q4 24 | $1.5M | $-7.9M | ||
| Q3 24 | $-3.7M | $4.6M | ||
| Q2 24 | $-1.3M | $18.3M | ||
| Q1 24 | $-8.0M | $3.0M |
| Q4 25 | 0.6% | 129.3% | ||
| Q3 25 | -5.0% | -48.3% | ||
| Q2 25 | -13.6% | -19.9% | ||
| Q1 25 | -30.1% | 3.5% | ||
| Q4 24 | 4.1% | -17.8% | ||
| Q3 24 | -10.3% | 8.7% | ||
| Q2 24 | -3.6% | 34.5% | ||
| Q1 24 | -22.5% | 5.4% |
| Q4 25 | 1.2% | 2.0% | ||
| Q3 25 | 2.6% | 0.1% | ||
| Q2 25 | 2.5% | 0.7% | ||
| Q1 25 | 1.4% | 0.5% | ||
| Q4 24 | 1.5% | 1.3% | ||
| Q3 24 | 2.4% | 0.8% | ||
| Q2 24 | 1.8% | 1.6% | ||
| Q1 24 | 1.9% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LAW
| Software | $35.1M | 85% |
| Services | $6.0M | 15% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
